
Richard B. Dagen
Partner
Richard ("Rick") Dagen is an antitrust partner who helps clients navigate complex litigation, government investigations, merger reviews, and strategic counseling matters. Drawing on more than three decades of experience—including senior leadership roles at the Federal Trade Commission (FTC)—Rick provides practical, strategic advice to companies facing their most significant antitrust challenges before the FTC, the U.S. Department of Justice, state attorneys general, and private plaintiffs.
Richard B. Dagen
Partner
Richard ("Rick") Dagen is an antitrust partner who helps clients navigate complex litigation, government investigations, merger reviews, and strategic counseling matters. Drawing on more than three decades of experience—including senior leadership roles at the Federal Trade Commission (FTC)—Rick provides practical, strategic advice to companies facing their most significant antitrust challenges before the FTC, the U.S. Department of Justice, state attorneys general, and private plaintiffs.

Rick has represented clients across a broad range of industries, including healthcare, technology, pharmaceuticals, medical devices, manufacturing, consumer products, and entertainment. His practice spans antitrust litigation (including class actions), merger clearance, government investigations, counseling, and competition issues at the intersection of intellectual property and antitrust.
Before joining Axinn, Rick spent more than 30 years at the FTC, where he served as both a trial lawyer and manager in many of the agency's most significant merger and conduct matters. As lead counsel and senior advisor, he helped shape enforcement involving mergers, monopolization, standard-setting, intellectual property, healthcare, and competition policy. Rick served in key roles (e.g., lead counsel, manager) in both federal and administrative trials and investigations involving some of the most important FTC merger and non-merger cases of the past thirty-plus years. For example, Rick successfully served as lead trial attorney in North Carolina State Board of Dental Examiners, a case that the Supreme Court affirmed. In addition, Rick had principal roles in Toys “R” Us, Three Tenors, Heinz, Rambus, Abbott Labs, Unocal, Intel, Dell, and Whole Foods. That experience gives clients valuable insight into how antitrust agencies evaluate investigations, litigation, and remedies.
Since joining Axinn, Rick has successfully represented clients in significant antitrust litigation, merger reviews, and counseling engagements. His work includes defending the University of Pittsburgh Medical Center in Sherman Act litigation and advising on numerous healthcare transactions, representing manufacturers in nationwide price-fixing and information exchange class actions, defending companies in standard-setting and competitor litigation, counseling clients on complex antitrust compliance issues, and advising trade associations on competition-related regulatory matters.
Rick is widely recognized for his contributions to antitrust law. He received the FTC's Brandeis Award for Outstanding Litigator and the FTC's Distinguished Service Award in recognition of his leadership and litigation accomplishments. Rick was recently included by Lawdragon in its “500 Leading Antitrust & Global Competition Lawyers” and its “500 Leading Dealmakers in America.” In addition, The National Law Journal selected Rick for its inaugural list of Antitrust Trailblazers.
Experience
- Representing PVC pipe manufacturers in class action cases brought by direct and indirect purchasers alleging price fixing and unlawful information exchange involving a third party conduit.
- Representing a caustic soda manufacturer in class action cases brought by direct and indirect purchasers alleging price fixing and output reductions.
- Represented a biotech company in antitrust class action involving standard setting conspiracy claims.
- Serving as antitrust counsel for the University of Pittsburgh Medical Center (UPMC), including successfully defending against Sherman Act claims in the Western District of Pennsylvania, and affirmed in the Third Circuit, as well as counseling regarding numerous hospital acquisitions since 2016. Most recently, Rick steered UPMC through investigations by the FTC and the Pennsylvania Attorney General’s Office in connection with the integration of Washington Hospital System.
- Played a principal role in getting Section 1 claims dismissed against Stanley Black & Decker in a matter involving collusion and standard setting activities.
- Represented the Alliance of Artists and Recording Companies (AARC) in the D.C. district court and D.C. Court of Appeals.
- Advocated on behalf of the Association of Dental Service Organizations before state boards and legislatures relating to potential anticompetitive rules, regulations, and enforcement actions.
Honors
- Named to the National Law Journal’s list of M&A and Antitrust Trailblazers.
- Lawdragon, “500 Leading Global Antitrust & Competition Lawyers” (2025 – 2026)
- Lawdragon, "500 Leading Dealmakers in America" (2024 – 2026)
- Rick was the recipient of the FTC’s Brandeis Award for Outstanding Litigator in 2000 and the FTC’s Award for Distinguished Service in 2014.
- Kramer Fellowship, a sabbatical year awarded each year to a staff person involved in antitrust from either the FTC or the Department of Justice, to Harvard Law School during 1997-1998.
Education
- JD – Emory University School of Law (1983)
- M.Phil – Yale University (1981)
- MA, Economics – Yale University (1980)
- BA – University of Chicago (1978)
Admissions
- District of Columbia
- U.S. Court of Appeals for the District of Columbia
- U.S. Court of Appeals for the Fourth Circuit
- U.S. District and Bankruptcy Courts for the District of Columbia
- U.S. District Court Northern District of Illinois
- U.S. District Court for the District of Maryland
- U.S. Supreme Court
Quotes
Axinn proves to have not just the necessary knowledge and skill to handle complex and sophisticated matters, but the depth of experience to anticipate unforeseen hurdles.
Chambers USA
Axinn is one of the most respected antitrust firms, and its reputation is well deserved.
Chambers USA
News & Insights
News & Insights
"Steering" Through Recent DOJ Complaints Involving Hospital Restrictions on Insurance Plans
Byline Articles
Antitrust
The Curtain Rises Again on FTC Act Section 5
Axinn Viewpoints
Lawdragon Names 27 Axinn Attorneys to its 2026 500 Leading Global Antitrust & Competition Lawyers Guide
Awards & Recognitions
Antitrust
Axinn Partners Named to Lawdragon's 2026 "500 Leading Dealmakers in America" Guide
Awards & Recognitions
Shifting Trends in Healthcare Antitrust Enforcement: Navigating the Evolving Landscape
Axinn Viewpoints
Antitrust
A Look At Trump 2.0 Antitrust Enforcement So Far
Byline Articles
Antitrust
Axinn Attorneys Named to Lawdragon 500 Leading Antitrust & Global Competition Lawyers Guide
Awards & Recognitions
Antitrust
Antitrust and the 2024 U.S. Elections: Is the Past Prologue?
Byline Articles
Antitrust
Axinn Partners Named to Lawdragon 500 Leading Dealmakers in America 2025
Awards & Recognitions
Antitrust
Presidents and Precedents May Direct Khan's Future Course
Axinn Viewpoints
Antitrust





